A Systematic Review and Meta-Analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence
- PMID: 35849299
- DOI: 10.1245/s10434-022-12197-6
A Systematic Review and Meta-Analysis on the Role of Repeat Breast-Conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence
Abstract
Introduction: The standard surgical management of ipsilateral breast cancer recurrence (IBCR) in patients previously treated with breast-conserving surgery (BCS) and radiotherapy (RT) is mastectomy. Recent international guidelines provide conflicting recommendations. The aim of this study was to perform a systematic literature review and meta-analysis of the oncological outcomes in patients with IBCR treated with repeat BCS (rBCS).
Methods: The MEDLINE and EMBASE databases were searched for relevant English-language publications, with no date restrictions. All relevant studies providing sufficient data to assess oncological outcomes (second local recurrence [LR] and overall survival [OS]) of rBCS for the management of IBCR after previous BCS and RT were included (PROSPERO registration CRD42021286123).
Results: Forty-two observational studies met the criteria and were included in the analysis. The pooled second LR rate after rBCS was 15.7% (95% confidence interval [CI] 12.1-19.7), and 10.3% (95% CI 6.9-14.3) after salvage mastectomy. On meta-analysis of comparative studies (n = 17), the risk ratio (RR) for second LR following rBCS compared with mastectomy was 2.103 (95% CI 1.535-2.883; p < 0.001, I2 = 55.1%). Repeat RT had a protective effect (coefficient: - 0.317, 95% CI - 0.596 to - 0.038; p = 0.026, I2 = 40.4%) for second LR. Pooled 5-year OS was 86.8% (95% CI 83.4-90.0) and 79.8% (95% CI 74.7-84.5) for rBCS and salvage mastectomy, respectively. Meta-analysis of comparative studies (n = 20) showed a small OS benefit in favor of rBCS (RR 1.040, 95% CI 1.003-1.079; p = 0.032, I2 = 70.8%). Overall evidence certainty was very low.
Conclusions: This meta-analysis suggests rBCS could be considered as an option for the management of IBCR in patients previously treated with BCS and RT. Shared decision making, appropriate patient selection, and individualized approach are important for optimal outcomes.
© 2022. Society of Surgical Oncology.
Similar articles
-
Breast conserving surgery versus salvage mastectomy for ipsilateral breast cancer recurrence: a propensity score matching analysis.Updates Surg. 2022 Apr;74(2):479-489. doi: 10.1007/s13304-021-01122-3. Epub 2021 Jun 28. Updates Surg. 2022. Retraction in: Updates Surg. 2022 Oct;74(5):1795. doi: 10.1007/s13304-022-01342-1. PMID: 34181187 Retracted.
-
Repeat Breast-Conserving Surgery Versus Salvage Mastectomy for Ipsilateral Breast Tumour Recurrence After Breast-Conserving Surgery in Breast Cancer Patients: A Meta-Analysis.Front Oncol. 2021 Nov 23;11:734719. doi: 10.3389/fonc.2021.734719. eCollection 2021. Front Oncol. 2021. PMID: 34888233 Free PMC article.
-
Local treatment options for young women with ductal carcinoma in situ: A systematic review and meta-analysis comparing breast conserving surgery with or without adjuvant radiotherapy, and mastectomy.Breast. 2022 Jun;63:29-36. doi: 10.1016/j.breast.2022.03.006. Epub 2022 Mar 12. Breast. 2022. PMID: 35299032 Free PMC article.
-
Ipsilateral Breast Cancer Recurrence: Characteristics, Treatment, and Long-Term Oncologic Results at a High-Volume Center.Clin Breast Cancer. 2021 Aug;21(4):329-336. doi: 10.1016/j.clbc.2020.12.006. Epub 2020 Dec 17. Clin Breast Cancer. 2021. PMID: 33431329
-
Surgical management of ipsilateral breast tumor recurrence.Int J Surg. 2015 Nov;23(Pt A):141-6. doi: 10.1016/j.ijsu.2015.08.084. Epub 2015 Oct 9. Int J Surg. 2015. PMID: 26449651
Cited by
-
"Enhancing survival outcomes through breast-conserving therapy in ipsilateral breast tumor recurrence: insights into metastasis and treatment strategies".Breast Cancer Res Treat. 2024 Feb;204(1):187. doi: 10.1007/s10549-023-07180-y. Epub 2023 Nov 24. Breast Cancer Res Treat. 2024. PMID: 37999917 No abstract available.
-
Oncoplastic breast-conserving surgery: advancing oncological outcomes and aesthetic standards in breast cancer treatment.Gland Surg. 2025 Apr 30;14(4):797-799. doi: 10.21037/gs-2024-572. Epub 2025 Apr 24. Gland Surg. 2025. PMID: 40405954 Free PMC article. No abstract available.
-
23rd Annual Meeting of the American Society of Breast Surgeons: Back to In-Person Scientific Exploration.Ann Surg Oncol. 2022 Oct;29(10):6087-6089. doi: 10.1245/s10434-022-12263-z. Epub 2022 Jul 28. Ann Surg Oncol. 2022. PMID: 35902494 Free PMC article. No abstract available.
-
Evaluation of Hologic LOCalizer™ RFID Tags for Preoperative Localization of Breast Lesions: A Single-Center Experience.Diagnostics (Basel). 2025 Mar 17;15(6):746. doi: 10.3390/diagnostics15060746. Diagnostics (Basel). 2025. PMID: 40150088 Free PMC article.
-
Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence.Ann Surg Oncol. 2024 Jul;31(7):4512-4517. doi: 10.1245/s10434-024-15282-0. Epub 2024 Apr 9. Ann Surg Oncol. 2024. PMID: 38594578
References
-
- Early Breast Cancer Trialists’ Collaborative Group. Effects of Radiotherapy and surgery in early breast cancer — an overview of the randomized trials. N Engl J Med. 1995;333(22):1444–56. - DOI
-
- Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378(9804):1707–16.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous